Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Effectiveness of a Novel Skin Barrier Protectant in the Prevention and Management of Acute Radiodermatitis in Patients With Head and Neck Cancer: a Prospective Cohort Study With Historical Controls

NCT04593914 is registered in ClinicalTrials.gov with Jessa Hospital as lead sponsor.

NCT NCT04593914
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04593914 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Effectiveness of a Novel Skin Barrier Protectant in the Prevention and Management of Acute Radiodermatitis in Patients With Head and Neck Cancer: a Prospective Cohort Study With Historical Controls
Lead sponsor
Jessa Hospital
Phase
Not applicable
Overall status
Withdrawn
Start date
September 1, 2020
Completion date
October 1, 2021
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer, radiation dermatitis, radiation toxicity, radiodermatitis, skin diseases